Clinical Trial Update: Dendritic Cells Therapy Combined With Immunomodulatory Treatment in Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating dendritic cell therapy combined with immunomodulatory treatment for Relapsing-Remitting Multiple Sclerosis is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Dendritic Cells Therapy

Snippet

Sponsor: Judit Pich | Conditions: Relapsing-Remitting Multiple Sclerosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING